Return
Leadless pacing
DOI:10.1007/s00059-018-4752-9.png)
Abstract
En 中文
Leadless self-contained intracardiac pacemakers were developed with the aim of abolishing the short- and long-term risk of lead- and pocket-related complications associated with transvenous devices. Leadless pacemakers promise minimally invasive procedures, long battery lives, and small amounts of foreign materials in the body. Experiences with the pioneering single-chamber devices have provided reasons for optimism about the future of the leadless concept. In the future, as more patients receive and live longer with implantable devices, the total risk of procedure- and lead-related complications is expected to increase, adding asense of urgency to the need for leadless alternatives to transvenous pacemakers. This review surveys the performance of currently available leadless pacemakers as well as emerging new innovative adaptations and applications of the leadless concept.
Keywords:
Single-chamber pacing
Cardiac resynchronization therapy
Implantable cardioverter-defibrillator
Dual-chamber pacing
Pacemaker
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
H
IF:
0.9
Papers:
55
Citations:
1.3K
Organization
Cited Papers
Leadless pacemaker versus transvenous single-chamber pacemaker therapy: A propensity score-matched analysis
HEART RHYTHM
IF5.7
Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment
HEART RHYTHM
IF5.7
A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry
HEART RHYTHM
IF5.7
Magnetic resonance imaging at 1.5-T in a patient with implantable leadless pacemaker
EUROPEAN HEART JOURNAL
IF35.6
Feasibility, safety, and short-term outcome of leadless ultrasound-based endocardial left ventricular resynchronization in heart failure patients: results of the Wireless Stimulation Endocardially for CRT (WiSE-CRT) study
EUROPACE
IF7.4
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)
EUROPEAN HEART JOURNAL
IF35.6

